Status | Study |
Completed |
Study Name: Risk of Narcolepsy Associated With Administration of H1N1 Vaccine Condition: Narcolepsy Date: 2011-07-12 Interventions: Biological: A/H1N1 vaccine Verify if exposure to Arepanrix vaccine increase risk of developing narcoleps |
Completed |
Study Name: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) Condition: Narcolepsy Cataplexy Date: 2011-06-21 Interventions: Drug: BF2.649 5,10,20,or 40 mg per day, in a once daily scheme |
Completed |
Study Name: Flumazenil for the Treatment of Primary Hypersomnia Condition: Hypersomnia Primary Hypersomnia Idiopathic Hypersomnia Date: 2010-08-09 Interventions: Drug: Flumazenil Sublingual flumazenil |
Completed |
Study Name: Clarithromycin for the Treatment of Hypersomnia Condition: Hypersomnia Idiopathic Hypersomnia Narcolepsy Date: 2010-06-15 Interventions: Drug: Clarithromycin followed by placebo |
Completed |
Study Name: Single-dose Safety Study of APD916 in Healthy Volunteers Condition: Narcolepsy With or Without Cataplexy Date: 2010-03-24 Interventions: Drug: APD916 |
Completed |
Study Name: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy Condition: Narcolepsy Cataplexy Excessiv Date: 2010-02-09 Interventions: Drug: BF2.649 BF2.649 oral cap |
Completed |
Study Name: Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy Condition: Narcolepsy Excessive Daytime Sleepiness Date: 2010-02-09 Interventions: Drug: BF2.649 BF2.649 oral cap |
Completed |
Study Name: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes Condition: Narcolepsy With Cataplexy Date: 2006-06-28 Interventions: Drug: Sodium Oxybate (Xyrem) Active Substance: Sodium Oxybate Pharmaceutical form: Oral Solution Concent |
Completed |
Study Name: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription Condition: Narcolepsy Date: 2005-10-24 |
Completed |
Study Name: Provigil (Modafinil) Study by Taiwan Biotech Co. Condition: Narcolepsy Cataplexy Sleep Di Date: 2005-09-14 Interventions: Drug: Modafinil |